Evaluation of Systemic Steroid Dosing, Asthma-Related Readmissions, and Body Mass Index in Pediatric Patients with Asthma

Persistent Link:
http://hdl.handle.net/10150/614018
Title:
Evaluation of Systemic Steroid Dosing, Asthma-Related Readmissions, and Body Mass Index in Pediatric Patients with Asthma
Author:
Tharmarajah, Soba; Phan, Hanna; Haftmann, Richard
Affiliation:
College of Pharmacy, The University of Arizona
Issue Date:
2016
Rights:
Copyright © is held by the author.
Collection Information:
This item is part of the Pharmacy Student Research Projects collection, made available by the College of Pharmacy and the University Libraries at the University of Arizona. For more information about items in this collection, please contact Jennifer Martin, Associate Librarian and Clinical Instructor, Pharmacy Practice and Science, jenmartin@email.arizona.edu.
Publisher:
The University of Arizona.
Abstract:
Objectives: The purpose of this study was to evaluate whether overweight/obese children with asthma have different systemic steroid dosing practices and asthma related readmission rates compared to normal/underweight children with asthma. Methods: Medical charts of patients admitted between October 2013 and October 2014 for an acute asthma exacerbation were reviewed retrospectively. The primary objective was to compare the average weight based systemic steroid dose between overweight/obese (Group 1) and normal/underweight (Group 2) with asthma. The secondary objective was to compare asthma-related readmissions between both groups. Data collected included demographic data; 30 day, 90 day and 6-month asthma-related readmissions; asthma medications prior-to-admission, during hospitalization and upon discharge. Results: One hundred fifty nine admissions (147 patients with recorded BMI) were evaluated. There was no significant difference in the proportion of obese, overweight, healthy and underweight patients who had 6-month asthma readmissions (p > 0.05). The mean systemic steroid, including prednisone and methylprednisolone, weight based dosing was similar between Group 1 and Group 2 (p > 0.05). Likewise, the proportion of patients with 6-month readmissions was similar in both groups (p > 0.05). Conclusions: Acute asthma exacerbation pediatric patients whom are overweight/obese were not being dosed differently to normal/underweight patients and were not at risk for increased asthma-related readmission in the following 6 months.
Description:
Class of 2016 Abstract
Keywords:
Steroid Dosing; Asthma-Related Readmissions; Body Mass Index; Pediatric Patients; Asthma
Advisor:
Phan, Hanna; Haftmann, Richard

Full metadata record

DC FieldValue Language
dc.contributor.advisorPhan, Hannaen
dc.contributor.advisorHaftmann, Richarden
dc.contributor.authorTharmarajah, Sobaen
dc.contributor.authorPhan, Hannaen
dc.contributor.authorHaftmann, Richarden
dc.date.accessioned2016-06-21T22:07:24Z-
dc.date.available2016-06-21T22:07:24Z-
dc.date.issued2016-
dc.identifier.urihttp://hdl.handle.net/10150/614018-
dc.descriptionClass of 2016 Abstracten
dc.description.abstractObjectives: The purpose of this study was to evaluate whether overweight/obese children with asthma have different systemic steroid dosing practices and asthma related readmission rates compared to normal/underweight children with asthma. Methods: Medical charts of patients admitted between October 2013 and October 2014 for an acute asthma exacerbation were reviewed retrospectively. The primary objective was to compare the average weight based systemic steroid dose between overweight/obese (Group 1) and normal/underweight (Group 2) with asthma. The secondary objective was to compare asthma-related readmissions between both groups. Data collected included demographic data; 30 day, 90 day and 6-month asthma-related readmissions; asthma medications prior-to-admission, during hospitalization and upon discharge. Results: One hundred fifty nine admissions (147 patients with recorded BMI) were evaluated. There was no significant difference in the proportion of obese, overweight, healthy and underweight patients who had 6-month asthma readmissions (p > 0.05). The mean systemic steroid, including prednisone and methylprednisolone, weight based dosing was similar between Group 1 and Group 2 (p > 0.05). Likewise, the proportion of patients with 6-month readmissions was similar in both groups (p > 0.05). Conclusions: Acute asthma exacerbation pediatric patients whom are overweight/obese were not being dosed differently to normal/underweight patients and were not at risk for increased asthma-related readmission in the following 6 months.en
dc.language.isoen_USen
dc.publisherThe University of Arizona.en
dc.rightsCopyright © is held by the author.en
dc.subjectSteroid Dosingen
dc.subjectAsthma-Related Readmissionsen
dc.subjectBody Mass Indexen
dc.subjectPediatric Patientsen
dc.subjectAsthmaen
dc.titleEvaluation of Systemic Steroid Dosing, Asthma-Related Readmissions, and Body Mass Index in Pediatric Patients with Asthmaen_US
dc.typetexten
dc.typeElectronic Reporten
dc.contributor.departmentCollege of Pharmacy, The University of Arizonaen
dc.description.collectioninformationThis item is part of the Pharmacy Student Research Projects collection, made available by the College of Pharmacy and the University Libraries at the University of Arizona. For more information about items in this collection, please contact Jennifer Martin, Associate Librarian and Clinical Instructor, Pharmacy Practice and Science, jenmartin@email.arizona.edu.en
All Items in UA Campus Repository are protected by copyright, with all rights reserved, unless otherwise indicated.